Clinical Trial Update: Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety, immunogenicity and preliminary efficacy of the PvDBPII vaccine candidate against Plasmodium vivax malaria; results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vivax Malaria

Drugs mentioned

• PvDBPII vaccine candidate (PvDBPII)

Snippet

Sponsor: University of Oxford | Conditions: Malaria, Vivax | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-25